Artiva Biotherapeutics, Inc. ARTV Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Artiva Biotherapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s cash ratio?
- Artiva Biotherapeutics, Inc. (ARTV) reported cash ratio of 2× in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s cash ratio changed year-over-year?
- Artiva Biotherapeutics, Inc.'s cash ratio decreased by 22.2% year-over-year, from 2.5× to 2×.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s cash ratio?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s cash ratio has grown at a -31.3% compound annual growth rate (CAGR), from 4.4× to 2.1×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.